These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1196613)

  • 21. Clofibrate and di(2-ethylhexyl)phthalate increase ubiquinone contents without affecting cholesterol levels.
    Aberg F; Appelkvist EL
    Acta Biochim Pol; 1994; 41(3):321-9. PubMed ID: 7856403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
    Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A kinetic comparison of the physiological effects of clofibrate and clofenapate in the rat.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(2):80-8. PubMed ID: 4459126
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of bis-(p-chlorophenoxy) acetic acid on serum lipids].
    Göres E; Rösner G; Spittka K; Kienast S
    Acta Biol Med Ger; 1976; 35(12):1745-7. PubMed ID: 1028331
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of clofibrate on aortic glycosamine-glycans and proteins and on serum lipid levels in experimental atherosclerosis.
    Bihari-Varga M; Fehér J; Varsányi M; Gerö S
    Acta Med Acad Sci Hung; 1973; 29(3):217-29. PubMed ID: 4270563
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of clofibrate on the polypeptide content of a purified fraction of rat liver peroxisomes].
    Antonenkov VD; Pirozhkov SV; Panchenko LF
    Biokhimiia; 1983 Sep; 48(9):1429-36. PubMed ID: 6626603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of clofibrate feeding on some lipogenic enzyme activities induced by high carbohydrate diet.
    Zelewski M; Swierczyński J
    Biochem Int; 1986 Oct; 13(4):591-8. PubMed ID: 3801034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of clofibrate on fatty acid desaturation of rats treated with ethanol.
    Peluffo RO; Nervi AM; Brenner RR
    Acta Physiol Lat Am; 1981; 31(2):119-28. PubMed ID: 6821269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of VULM 1457, an ACAT inhibitor, on serum lipid levels and on real time red blood cell flow in diabetic and non-diabetic hamsters fed high cholesterol-lipid diet.
    Vojtassáková E; Syneková M; Tazká D; Mátyás S; Hózová R; Sadlonová I; Svec P
    Gen Physiol Biophys; 2007 Dec; 26(4):254-9. PubMed ID: 18281742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of chemically different calcium antagonists on lipid profile in rats fed on a high fat diet.
    Guido S; Joseph T
    Indian J Exp Biol; 1992 Apr; 30(4):292-4. PubMed ID: 1459596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clofibrate-induced alterations in serum protein patterns.
    Powanda MC; Henriksen EL; Ayala E; Canonico PG
    Biochem Pharmacol; 1976 Apr; 25(7):785-8. PubMed ID: 938580
    [No Abstract]   [Full Text] [Related]  

  • 32. Does clofibrate mobilize cholesterol from tissues?
    Rothfeld B; Karmen A; Hunter CF; Varady A
    Biochem Med; 1971 Apr; 5(2):165-72. PubMed ID: 5131450
    [No Abstract]   [Full Text] [Related]  

  • 33. [Preliminary study of the effects of nicotinic-N-oxide acid causing hypolipidemia administered alone or in combination with clofibrate].
    Palamara G; De Luca G; Materazzi M
    Boll Chim Farm; 1977 Oct; 116(10):596-600. PubMed ID: 607948
    [No Abstract]   [Full Text] [Related]  

  • 34. Triparanol-induced desmoterol accumulation in clofibrate-effected hypocholesterolemia.
    Arnold A; Powers LG; McAuliff JP
    Atherosclerosis; 1974; 20(2):401-4. PubMed ID: 4416741
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolic effects of prolonged ethanol administration in rats treated with clofibrate.
    Hillbom ME; Pösö AR; Eriksson CJ; Franssila K; Häkkinen HM
    Acta Pharmacol Toxicol (Copenh); 1976 Sep; 39(3):365-73. PubMed ID: 989682
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacological testing of an acetylate derivative of glucose. II. Biochemical and pharmacodynamic data].
    Mungiu OC; Papa V; Vultureanu M; Popescu M; Grigorescu S; Oiţă N
    Rev Med Chir Soc Med Nat Iasi; 1983; 87(1):83-6. PubMed ID: 6676840
    [No Abstract]   [Full Text] [Related]  

  • 37. Cooperative clofibrate trial.
    Leibowitz BJ
    JAMA; 1979 Dec; 242(24):2663-4. PubMed ID: 387985
    [No Abstract]   [Full Text] [Related]  

  • 38. The passage of 14C-labelled clofibrate through the liver [proceedings].
    Laker ME; Mayes PA
    Biochem Soc Trans; 1978; 6(3):583-4. PubMed ID: 669019
    [No Abstract]   [Full Text] [Related]  

  • 39. Morphological changes in the liver of rats treated with a new hypolipidemic agent, S-8527.
    Sakamoto SI; Yamada K; Anzai T; Wada T
    Atherosclerosis; 1973; 18(1):109-16. PubMed ID: 4741528
    [No Abstract]   [Full Text] [Related]  

  • 40. The clofibrate problem: a different viewpoint.
    Lancet; 1980 Nov; 2(8203):1081-2. PubMed ID: 6107704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.